BioCentury | Aug 3, 2018
Clinical News

CHMP positive on patisiran, Symkevi, Humira and Neulasta biosimilars

...neutropenia drug Neulasta pegfilgrastim also got nods from CHMP, including Pelgraz from Accord Healthcare Ltd. (Middlesex...
BioCentury | Jul 27, 2018
Company News

CHMP positive on patisiran, Symkevi, Humira and Neulasta biosimilars

...neutropenia drug Neulasta pegfilgrastim also got nods from CHMP, including Pelgraz from Accord Healthcare Ltd. (Middlesex...
BioCentury | Jul 13, 2018
Company News

Celgene, Accord settle Revlimid patent litigation

...Celgene Corp. (NASDAQ:CELG) granted Accord Healthcare Ltd. (Middlesex, U.K.) rights to market an authorized generic version...
...lymphoma (MCL). It is a thalidomide analog. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Accord Healthcare Ltd., Middlesex...
BioCentury | Jul 22, 2013
Company News

Otsuka Pharmaceutical pharmaceuticals news

...headquarters. The newco, which has €1 million ($1.3 million) in capital, will be located in Middlesex...
BioCentury | Mar 24, 2011
Tools & Techniques

Hypoxic homing in prostate cancer

...2011 Companies and Institutions Mentioned AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Mount Vernon Hospital , Middlesex...
BioCentury | Jan 17, 2011
Financial News

SeraCare financial update

...a $15 million term loan facility and a $5 million revolving line of credit with Middlesex...
BioCentury | Aug 30, 2010
Product Development

Environmental Activism

...at the Yale University School of Medicine ; president of the American Cancer Society 's Middlesex...
BioCentury | Mar 22, 2010
Company News

Horizon Discovery Ltd., ValiRx, Laboratory of Government Chemistry Ltd. deal

...Ltd. , Cambridge, U.K. ValiRx plc (LSE:VAL), London, U.K. Laboratory of Government Chemistry Ltd. , Middlesex...
BioCentury | Sep 15, 2008
Company News

Alfama, hemoCORM Ltd. deal

...liver failure and multiple sclerosis (MS). Alfama Inc. , Porto Salvo, Portugal hemoCORM Ltd. , Middlesex...
BioCentury | Aug 7, 2006
Clinical News

MoviPrep regulatory update

...Norgine. MGI Pharma Inc. (MOGN), Bloomington, Minn. SuperGen Inc. (SUPG), Dublin, Calif. Norgine B.V. , Middlesex...
Items per page:
1 - 10 of 30
BioCentury | Aug 3, 2018
Clinical News

CHMP positive on patisiran, Symkevi, Humira and Neulasta biosimilars

...neutropenia drug Neulasta pegfilgrastim also got nods from CHMP, including Pelgraz from Accord Healthcare Ltd. (Middlesex...
BioCentury | Jul 27, 2018
Company News

CHMP positive on patisiran, Symkevi, Humira and Neulasta biosimilars

...neutropenia drug Neulasta pegfilgrastim also got nods from CHMP, including Pelgraz from Accord Healthcare Ltd. (Middlesex...
BioCentury | Jul 13, 2018
Company News

Celgene, Accord settle Revlimid patent litigation

...Celgene Corp. (NASDAQ:CELG) granted Accord Healthcare Ltd. (Middlesex, U.K.) rights to market an authorized generic version...
...lymphoma (MCL). It is a thalidomide analog. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Accord Healthcare Ltd., Middlesex...
BioCentury | Jul 22, 2013
Company News

Otsuka Pharmaceutical pharmaceuticals news

...headquarters. The newco, which has €1 million ($1.3 million) in capital, will be located in Middlesex...
BioCentury | Mar 24, 2011
Tools & Techniques

Hypoxic homing in prostate cancer

...2011 Companies and Institutions Mentioned AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Mount Vernon Hospital , Middlesex...
BioCentury | Jan 17, 2011
Financial News

SeraCare financial update

...a $15 million term loan facility and a $5 million revolving line of credit with Middlesex...
BioCentury | Aug 30, 2010
Product Development

Environmental Activism

...at the Yale University School of Medicine ; president of the American Cancer Society 's Middlesex...
BioCentury | Mar 22, 2010
Company News

Horizon Discovery Ltd., ValiRx, Laboratory of Government Chemistry Ltd. deal

...Ltd. , Cambridge, U.K. ValiRx plc (LSE:VAL), London, U.K. Laboratory of Government Chemistry Ltd. , Middlesex...
BioCentury | Sep 15, 2008
Company News

Alfama, hemoCORM Ltd. deal

...liver failure and multiple sclerosis (MS). Alfama Inc. , Porto Salvo, Portugal hemoCORM Ltd. , Middlesex...
BioCentury | Aug 7, 2006
Clinical News

MoviPrep regulatory update

...Norgine. MGI Pharma Inc. (MOGN), Bloomington, Minn. SuperGen Inc. (SUPG), Dublin, Calif. Norgine B.V. , Middlesex...
Items per page:
1 - 10 of 30